Search Results
Search for other papers by Tae-Hwan Kim in
Google Scholar
PubMed
Search for other papers by Mi Yeon Lee in
Google Scholar
PubMed
Search for other papers by Sung Min Jin in
Google Scholar
PubMed
Search for other papers by Sang Hyuk Lee in
Google Scholar
PubMed
The impact of serum thyroid hormone levels on thyroid cancer risk is unclear. Some studies reported that elevated thyroid-stimulating hormone (TSH) is associated with higher risk for incidence of thyroid cancer, but other studies reported no relationship. We conducted a large cohort study in 164,596 South Korean men and women who were free of thyroid cancer at baseline and underwent health examination with hormone levels of thyroid function. A parametric proportional hazard model was used to evaluate the adjusted hazard ratio (HR) and 95% CI. During 2,277,749.78 person-years of follow-up, 1280 incident thyroid cancers were identified (men = 593, women = 687). Among men, the multivariable-adjusted HR (95% CI) for thyroid cancer comparing low levels of TSH with normal levels of TSH was 2.95 (1.67–5.23), whereas the corresponding HR (95% CI) in women was 1.5 (0.88–2.55). High levels of free T4 and free T3 were also associated with incident thyroid cancer in both men and women. In clinical implication, overt hyperthyroidism is associated with thyroid cancer in both men and women. Within the euthyroid range, the highest tertile of TSH was associated with a lower risk of thyroid cancer than the lowest TSH tertile and the highest FT4 tertile was associated with a higher risk of thyroid cancer than the lowest FT4 tertile in both men and women. Our finding indicates that low levels of TSH and high levels of FT4, even within the normal range, were associated with an increased risk of incident thyroid cancer.
Search for other papers by Tommaso Porcelli in
Google Scholar
PubMed
Search for other papers by Raffaele Ambrosio in
Google Scholar
PubMed
Search for other papers by Maria Angela De Stefano in
Google Scholar
PubMed
Search for other papers by Cristina Luongo in
Google Scholar
PubMed
Search for other papers by Daniela Terracciano in
Google Scholar
PubMed
Search for other papers by Caterina Miro in
Google Scholar
PubMed
Search for other papers by Monica Dentice in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
CEINGE Biotecnologie Avanzate Scarl, Naples, Italy
Search for other papers by Domenico Salvatore in
Google Scholar
PubMed
Treatment with tyrosine kinase inhibitors (TKIs) has been associated with alterations in circulating thyroid hormone levels, possibly related to perturbations in peripheral thyroid hormone metabolism. In this study, we evaluated the effect of the multi-kinase inhibitor vandetanib on the expression of the three deiodinase selenoenzymes, responsible for the thyroid hormone activation (type 1 and type 2 deiodinases) or for its inactivation (type 3 deiodinase). Here, we show that the multi-kinase inhibitor vandetanib determines a strong cell-specific downregulation of type 2 deiodinase (D2) expression and a significant reduction in D2 enzymatic activity. This occurs in the diffused population of fibro/adipogenic progenitors, which reside in different tissues – including the muscles – and normally express D2. Given the widespread diffusion of mesenchymal cells within the body, our results may explain at least partially the alterations in thyroid hormone levels that occur in vandetanib-treated patients. Our findings represent a step forward into the understanding of the mechanisms by which TKIs induce hypothyroidism and identify a resident cell population in which such an effect takes place.
Occupational and Environmental Epidemiology Branch, Department of Health Studies, Radiation Epidemiology Branch, Core Genotype Facility, Biostatistics Branch, Department of Head and Neck Surgery, Information Management Services, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Search for other papers by Briseis Aschebrook-Kilfoy in
Google Scholar
PubMed
Search for other papers by Gila Neta in
Google Scholar
PubMed
Search for other papers by Alina V Brenner in
Google Scholar
PubMed
Search for other papers by Amy Hutchinson in
Google Scholar
PubMed
Search for other papers by Ruth M Pfeiffer in
Google Scholar
PubMed
Search for other papers by Erich M Sturgis in
Google Scholar
PubMed
Search for other papers by Li Xu in
Google Scholar
PubMed
Search for other papers by William Wheeler in
Google Scholar
PubMed
Search for other papers by Michele M Doody in
Google Scholar
PubMed
Search for other papers by Stephen J Chanock in
Google Scholar
PubMed
Search for other papers by Alice J Sigurdson in
Google Scholar
PubMed
NAT2 ( Hernández et al . 2008 , Lemos et al . 2008 , Guilhen et al . 2009 ). Thus, there is some evidence of associations for thyroid cancer with polymorphisms in genes related to thyroid hormone metabolism and detoxification enzymes, but the
Search for other papers by Loredana Bianchi in
Google Scholar
PubMed
Search for other papers by Luigi Rossi in
Google Scholar
PubMed
Search for other papers by Federica Tomao in
Google Scholar
PubMed
Search for other papers by Anselmo Papa in
Google Scholar
PubMed
Search for other papers by Federica Zoratto in
Google Scholar
PubMed
Search for other papers by Silverio Tomao in
Google Scholar
PubMed
autoimmunological background. Thyroid hormone metabolism Abdulrahman hypothesized the influence of sorafenib on iodothyronine deiodinase (D1, D2, and D3) activity, resulting in enhanced T 4 and T 3 metabolism that may contribute to hypothyroidism during sorafenib
Université Paris-Sud Orsay, Île-de-France, France
Gustave Roussy, Villejuif, France
Search for other papers by Monia Zidane in
Google Scholar
PubMed
Search for other papers by Jean-Baptiste Cazier in
Google Scholar
PubMed
Search for other papers by Sylvie Chevillard in
Google Scholar
PubMed
Search for other papers by Catherine Ory in
Google Scholar
PubMed
Gustave Roussy, Villejuif, France
UMR 8200 CNRS, Villejuif, France
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Gustave Roussy, Villejuif, France
UMR 8200 CNRS, Villejuif, France
Search for other papers by Corinne Dupuy in
Google Scholar
PubMed
Search for other papers by Jean-François Deleuze in
Google Scholar
PubMed
Search for other papers by Anne Boland in
Google Scholar
PubMed
Université Paris-Sud Orsay, Île-de-France, France
Gustave Roussy, Villejuif, France
Search for other papers by Nadia Haddy in
Google Scholar
PubMed
PSL Research University, Paris, France
INSERM, U900, Paris, France
Mines Paris Tech, Fontainebleau, France
Search for other papers by Fabienne Lesueur in
Google Scholar
PubMed
Université Paris-Sud Orsay, Île-de-France, France
Gustave Roussy, Villejuif, France
Search for other papers by Florent de Vathaire in
Google Scholar
PubMed
in LIG1 , one was in ALKBH3 and one was in ERCC2 . Other SNPs associated to radiation-related DTC are in or near genes involved in thyroid hormone metabolism such as FOXE1 , TSHR and NKX2-1. The latter are associated with both sporadic and
Search for other papers by Helena Andrea Sterle in
Google Scholar
PubMed
Search for other papers by Ximena Hildebrandt in
Google Scholar
PubMed
Search for other papers by Matías Valenzuela Álvarez in
Google Scholar
PubMed
Search for other papers by María Alejandra Paulazo in
Google Scholar
PubMed
Search for other papers by Luciana Mariel Gutierrez in
Google Scholar
PubMed
Search for other papers by Alicia Juana Klecha in
Google Scholar
PubMed
Search for other papers by Florencia Cayrol in
Google Scholar
PubMed
Search for other papers by María Celeste Díaz Flaqué in
Google Scholar
PubMed
Search for other papers by Cinthia Rosemblit in
Google Scholar
PubMed
Search for other papers by María Laura Barreiro Arcos in
Google Scholar
PubMed
Search for other papers by Lucas Colombo in
Google Scholar
PubMed
Search for other papers by Marcela Fabiana Bolontrade in
Google Scholar
PubMed
Search for other papers by Vanina Araceli Medina in
Google Scholar
PubMed
Search for other papers by Graciela Alicia Cremaschi in
Google Scholar
PubMed
postmenopausal women . Breast Cancer Research 12 R33. ( https://doi.org/10.1186/bcr2587 ) van der Spek AH Fliers E Boelen A 2017 The classic pathways of thyroid hormone metabolism . Molecular and Cellular Endocrinology 458 29 – 38 . ( https
Section on Endocrinology Genetics, Pediatric Endocrinology Inter-Institute Training Program, Program on Developmental Endocrinology Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Search for other papers by Maya B Lodish in
Google Scholar
PubMed
Section on Endocrinology Genetics, Pediatric Endocrinology Inter-Institute Training Program, Program on Developmental Endocrinology Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Search for other papers by Constantine A Stratakis in
Google Scholar
PubMed
TKIs has raised the awareness of adverse affects on thyroid hormone function and/or thyroid hormone metabolism, as outlined in Table 2 . As a result of these studies, it is now recommended that all patients starting therapy with TKIs have their thyroid
Search for other papers by Maria Angela De Stefano in
Google Scholar
PubMed
Search for other papers by Tommaso Porcelli in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
CEINGE Biotecnologie Avanzate Scarl, Naples, Italy
Search for other papers by Domenico Salvatore in
Google Scholar
PubMed
Battiprolu PK Nguyen A , 2020 FoxO1-Dio2 signaling axis governs cardiomyocyte thyroid hormone metabolism and hypertrophic growth . Nature Communications 11 2551. ( https://doi.org/10.1038/s41467-020-16345-y ) 32439985 Field JB Ealey PA Marshall
Search for other papers by T M A Kerkhofs in
Google Scholar
PubMed
Search for other papers by M H T Ettaieb in
Google Scholar
PubMed
Search for other papers by I G C Hermsen in
Google Scholar
PubMed
Department of Internal Medicine, Division of General Internal Medicine, Department of Health Services Research and CAPHRI School for Public Health and Primary Care, Maxima Medical Center, Ds. Th. Fliednerstraat 1, 5631 BM Eindhoven/Veldhoven, The Netherlands
Department of Internal Medicine, Division of General Internal Medicine, Department of Health Services Research and CAPHRI School for Public Health and Primary Care, Maxima Medical Center, Ds. Th. Fliednerstraat 1, 5631 BM Eindhoven/Veldhoven, The Netherlands
Search for other papers by H R Haak in
Google Scholar
PubMed
effect on the pituitary gland or induction of thyroid hormone metabolism ( Zatelli et al . 2010 ). Based on clinical experience, treatment with thyroxine supplementation restores euthyroidism. In men with signs of hypogonadism, assessment of testosterone
Search for other papers by Kathrin A Schmohl in
Google Scholar
PubMed
Search for other papers by Peter J Nelson in
Google Scholar
PubMed
Search for other papers by Christine Spitzweg in
Google Scholar
PubMed
.11.7.1376 ) 10.1200/JCO.1993.11.7.1376 Wu SY Green WL Huang WS Hays MT Chopra IJ 2005 Alternate pathways of thyroid hormone metabolism . Thyroid 15 943 – 958 . ( https://doi.org/10.1089/thy.2005.15.943 ) 10.1089/thy.2005.15.943 16131336 Xie TX Xia Z